Adult Idiopathic Thrombocytopenic Purpura

References

• Bottiger, L.E. and Westerholm, B. (1972) "Thrombocyto-penia. I. Incidence and aetiology", Acta Medical Scandinavica 191, 535–540.
   PubMed Web of Science ®Google Scholar
• McMillan, R. (1997) "Therapy for adults with refractory chronic immune thrombocytopenic purpura", Annals of Internal Medicine 126, 307–314.
   PubMed Web of Science ®Google Scholar
• Waters, A.H. (1992) "Autoimmune thrombocytopenia: clinical aspects", Seminars in Hematology 29, 18–25.
   PubMed Web of Science ®Google Scholar
• Harrington, W.J., Minnich, V, Hollingsworth, J.W. and Moore, C.V. (1951) "Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura", Journal of Laboratory and Clinical Medicine 38, 1–10.
   PubMed Web of Science ®Google Scholar
• Mackay, I.R. (2000) "Tolerance and autoimmunity", British Medical Journal 321, 93–96.
   PubMed Web of Science ®Google Scholar
• Gautam, A.M., Lock, C.B., Smilek, D.E., Pearson, CI., Steinman, L. and McDevitt, H.O. (1994) "Minimum structural requirements for peptide presentation by major histocompatibility complex class II molecules: implications in induction of autoimmunity", Proceedings of the National Academy of Sciences of the United States of America 91,767–771.
   PubMed Web of Science ®Google Scholar
• Haines, J.L., Ter-Minassian, M., Bazyk, A., Gusella, J.F., Kim, D.J., Terwedow, H., Pericak-Vance, M.A, Rimmler, J.B., Haynes, CS., Roses, A.D., Lee, A., Shaner, B., Menold, M., Seboun, E., Fitoussi, RE, Gartioux, C., Reyes, C., Ribierre, F., Gyapay, G., Weissenbach, J., Hauser, S.L., Goodkin, D.E., Lincoln, R., Usuku, K. and Oksenberg, J.R. (1996) "A complete genomic screen for multiple sclerosis under-scores a role for the major histocompatability complex. The Multiple Sclerosis Genetics Group", Nature Genetics 13, 469–471.
   PubMed Web of Science ®Google Scholar
• Nomura, S., Matsuzaki, T., Ozaki, Y., Yamaoka, M., Yoshimura, C., Katsura, K., Xie, G.L., Kagawa, H., Ishida, T. and Fukuhara, S. (1998) "Clinical significance of HLA-DRB1*0410 in Japanese patients with idiopathic thrombo-cytopenic purpura", Blood 91, 3616–3622.
   PubMed Web of Science ®Google Scholar
• Stanworth, S.J., Turner, D.M., Brown, J., McCloskey, D., Brown, C., Provan, D., Navarrete, C.V. and Newland, A.C. (2002) "Major histocompatibility complex susceptibility genes and immune thrombocytopenic purpura in Caucasian adults", Hematology 7, 119–121.
   PubMedGoogle Scholar
• Cines, D.B. and Blanchette, V.S. (2002) "Immune thrombo-cytopenic purpura", New England Journal of Medicine 346, 995–1008.
   PubMed Web of Science ®Google Scholar
• Ridgway, W.M. and Fathman, C.G. (1998) "The association of MHC with autoimmune diseases: understanding the pathogenesis of autoimmune diabetes", Clinical Immunology and Immunopathology 86, 3–10.
   PubMedGoogle Scholar
• Ermann, J. and Fathman, C.G. (2001) "Autoimmune diseases: genes, bugs and failed regulation", Nature Immunology 2, 759–761.
   PubMed Web of Science ®Google Scholar
• Schwartz, M. and Cohen, I.R. (2000) "Autoimmunity can benefit self maintenance", Immunology Today 21, 265–268.
   PubMedGoogle Scholar
• Refaeli, Y, Van Parijs, L. and Abbas, A.K. (1999) "Genetic models of abnormal apoptosis in lymphocytes", Immuno-logical Reviews 169, 273–282.
   PubMed Web of Science ®Google Scholar
• Straus, SE., Sneller, M., Lenardo, M.J., Puck, J.M. and Strober, W. (1999) "An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syn-drome", Annals of Internal Medicine 130, 591–601.
   PubMed Web of Science ®Google Scholar
• Wucherpfennig, K.W. and Eisenbarth, G.S. (2001) "Type 1 diabetes", Nature Immunology 2, 767–768.
   PubMed Web of Science ®Google Scholar
• Stockinger, B. (1999) "T lymphocyte tolerance: from thymic deletion to peripheral control mechanisms", Advances in Immunology 71, 229–265.
   PubMedGoogle Scholar
• Semple, J.W., Miley, Y., Cosgrave, D., Mody, M., Hornstein, A., Blanchette, V. and Freedman, J. (1996) "ifferences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: relationship to platelet pheno-type and antiplatelet T-cell reactivity", Blood 87, 4245–4254.
   PubMed Web of Science ®Google Scholar
• Schwartz, R.S. (2003) "Shattuck lecture—diversity of the immune repertoire and immunoregulation", New England Journal of Medicine 348, 1017–1026.
   PubMed Web of Science ®Google Scholar
• Bettaieb, A., Oksenhendler, E., Duedari, N. and Bierling, P. (1996) "Cross-reactive antibodies between WV gp120 and platelet gpflila (CD61) in HIV-related immune thrombocyto-penic purpura", Clinical and Experimental Immunology 103, 19–23.
   PubMed Web of Science ®Google Scholar
• Kiefel, V, Freitag, E., Kroll, H., Santoso, S. and Mueller-Eckhardt, C. (1996) "Platelet autoantibodies (IgG, IgM, IgA) against glycoproteins/Ma and lb /IX in patients with thrombocytopenia", Annals of Hematology 72, 280–285.
   PubMed Web of Science ®Google Scholar
• Berchtold, P. and Wenger, M. (1993) "Autoantibodies against platelet glycoproteins in autoimmune thrombocytopenic purpura: their clinical significance and response to treatment", Blood 81, 1246–1250.
   PubMed Web of Science ®Google Scholar
• Brighton, T.A., Evans, S., Castaldi, P.A., Chesterman, C.N. and Chong, B.H. (1996) "Prospective evaluation of the clinical usefulness of an antigen-specific assay (MAlPA) in idiopathic thrombocytopenic purpura and other immune thrombocytopenias", Blood 88, 194–201.
   PubMed Web of Science ®Google Scholar
• Macchi, L., Clofent-Sanchez, G., Marit, G., Bihour, C., Durrieu-Jais, C., Besse, P., Nurden, P. and Nurden, A.T. (1996) "PAICA: a method for characterizing platelet-associated antibodies—its application to the study of idiopathic thrombocytopenic purpura and to the detection of platelet-bound c7E3", Thrombosis and Haemostasis 76, 1020–1029.
   PubMed Web of Science ®Google Scholar
• Warner, M. and Kelton, J.G. (1997) "Laboratory investigation of immune thrombocytopenia", Journal of Clinical Pathology 50, 5–12.
   PubMed Web of Science ®Google Scholar
• Warner, M.N., Moore, J.C., Warkentin, T.E., Santos, A.V. and Kelton, J.G. (1999) "A prospective study of protein-specific assays used to investigate idiopathic thrombocytopenic purpura", British Journal of Haematology 104, 442–447.
   PubMed Web of Science ®Google Scholar
• Stockelberg, D., Hou, M., Jacobsson, S., Kutti, J. and Wadenvik, H. (1995) "Evidence for a light chain restriction of glycoprotein lb /IX and/Ma reactive antibodies inchronic idiopathic thrombocytopenic purpura (ITP)", British Journal of Haematology 90, 175–179.
   PubMed Web of Science ®Google Scholar
• Hou, M., Stockelberg, D., Kutti, J. and Wadenvik, H. (1995) "Glycoprotein/Ma autoantigenic repertoire in chronicidiopathic thrombocytopenic purpura", British Journal of Haematology 91, 971–975.
   PubMed Web of Science ®Google Scholar
• McMillan, R., Tani, P., Millard, F., Berchtold, P., Renshaw, L. and Woods, V.L. Jr., (1987) "Platelet-associated and plasma anti-glycoprotein autoantibodies in chronic ITP", Blood 70, 1040–1045.
   PubMed Web of Science ®Google Scholar
• Kiefel, V, Santoso, S., Kaufmann, E. and Mueller-Eckhardt, C. (1991) "Autoantibodies against platelet glycoprotein lb /A: a frequent finding in autoimmune thrombocytopenic purpura", British Journal of Haematology 79, 256–262.
   PubMed Web of Science ®Google Scholar
• McMillan, R., Lopez-Dee, J. and Bowditch, R. (2001) "Clonal restriction of platelet-associated anti-GPM/lila autoanti-bodies in patients with chronic ITP", Thrombosis and Haemostasis 85, 821–823.
   PubMed Web of Science ®Google Scholar
• Roark, J.H., Bussel, J.B., Cines, D.B. and Siegel, D.L. (2002) "Genetic analysis of autoantibodies in idiopathic thrombo-cytopenic purpura reveals evidence of clonal expansion and somatic mutation", Blood 100, 1388–1398.
   PubMed Web of Science ®Google Scholar
• Garvey, B. (1998) "Management of chronic autoimmune thrombocytopenic purpura (ITP) in adults", Transfusion Science 19, 269–277.
   PubMedGoogle Scholar
• Nieswandt, B., Bergmeier, W., Rackebrandt, K., Gessner, J.E. and Zirngibl, H. (2000) "Identification of critical antigen-specific mechanisms in the development of immune thrombocytopenic purpura in mice", Blood 96, 2520–2527.
   PubMed Web of Science ®Google Scholar
• Wang, Z.Y. and Shen, Z.X. (1997) "Megakaryocytes and platelets in immune thrombocytopenic purpura", Bailliere's Clinical Haematology 10, 89–107.
   PubMed Web of Science ®Google Scholar
• Karpatkin, S. (1985) "Autoimmune thrombocytopenic purpura", Seminars in Hematology 22, 260–288.
   PubMed Web of Science ®Google Scholar
• Cahill, M.R. and Newland, A.C. (1997) "Is it refractory idiopathic thrombocytopenic purpura?", Lancet 349, 1066.
   PubMed Web of Science ®Google Scholar
• Balduini, C.L., Iolascon, A. and Savoia, A. (2002) "Inherited thrombocytopenias: from genes to therapy", Haematologica 87, 860–880.
   PubMed Web of Science ®Google Scholar
• Doan, C.A., Bouroncle, B.A. and Wiseman, B.K. (1960) "Idiopathic and secondary thrombocytopenic purpura. Clinical study and evaluation of 381 cases over a period on 28 years", Annals of Internal Medicine 53, 861–876.
   Web of Science ®Google Scholar
• Charie, A.L., Harrison, P., Smith, CB., Cobb, J.R., Briggs, C. and Machin, S. (2001) "Accuracy in the low platelet count range: a comparison of automated platelet counts on Beckman Coulter High-Volume Hematology Analyzers With the ISLH/ICSH Platelet Reference Method", Laboratory Haematology 7, 236–244.
   Google Scholar
• Pegels, J.G., Bruynes, E.C., Engelfriet, C.P. and von dem Borne, A.E. (1982) "Pseudothrombocytopenia: an immuno-logic study on platelet antibodies dependent on ethylene diamine tetra-acetate", Blood 59, 157–161.
   PubMed Web of Science ®Google Scholar
• George, J.N., Woolf, S.H., Raskob, G.E., Wasser, J.S., Aledort, L.M., Ballem, P.J., Blanchette, VS., Bussel, J.B., Cines, D.B., Kelton, J.G., Lichtin, A.E., McMillan, R., Okerbloom, J.A., Regan, D.H. and Warner, I. (1996) "Idiopathic thrombo-cytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology", Blood 88, 3–40.
   PubMed Web of Science ®Google Scholar
• Ballem, P.J., Segal, G.M., Stratton, J.R., Gernsheimer, T., Adamson, J.W. and Slichter, S.J. (1987) "Mechanisms of thrombocytopenia in chronic autoimmune thrombocyto-penic purpura. Evidence of both impaired platelet pro-duction and increased platelet clearance", Journal of Clinical Investigation 80, 33–40.
   PubMed Web of Science ®Google Scholar
• Mak, Y.K., Yu, P.H., Chan, C.H. and Chu, Y.C. (2000) "The management of isolated thrombocytopenia in Chinese adults: does bone marrow examination have a role at presentation?", Clinical and Laboratory Haematology 22, 355–358.
   PubMedGoogle Scholar
• von dem Borne, A.E., Vos, J.J., van der Lelie, J., Bossers, B. and van Dalen, C.M. (1986) "Clinical significance of positive platelet immunofluorescence test in thrombocytopenia", British Journal of Haematology 64, 767–776.
   PubMed Web of Science ®Google Scholar
• Kelton, J.G., Murphy, W.G., Lucarelli, A., Garvey-Williams, J., Santos, A., Meyer, R. and Powers, P. (1989) "A prospective comparison of four techniques for measuring platelet associated IgG", British Journal of Haematology 71, 97–105.
   PubMed Web of Science ®Google Scholar
• Porcelijn, L., Folman, C.C., Bossers, B., Huiskes, E., Over-beeke, M.A, v.d.Schoot, C.E., de Haas, M. and von dem Borne, A.E. (1998) "The diagnostic value of thrombopoietin level measurements in thrombocytopenia", Thrombosis and Haemostasis 79, 1101–1105.
   PubMed Web of Science ®Google Scholar
• Emmons, R.V., Reid, D.M., Cohen, R.L., Meng, G., Young, N.S., Dunbar, C.E. and Shulman, N.R. (1996) "Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction", Blood 87, 4068–4071.
   PubMed Web of Science ®Google Scholar
• Saxon, B.R., Blanchette, VS., Butchart, S., Lim-Yin, J. and Poon, A.O. (1998) "Reticulated platelet counts in the diagnosis of acute immune thrombocytopenic purpura", Journal of Pediatric Hematology/Oncology 20, 44–48.
   PubMed Web of Science ®Google Scholar
• Provan, D.R. and Newland, A.C. (2002) "Fifty years of idiopathic thrombocytopenic purpura (ITP): management of refractory ITP in adults", British Journal of Haematology 118, 933–944.
   PubMed Web of Science ®Google Scholar
• Provan, D., Newland, A., Norfolk, D., Bolton-Maggs, P., Lilleyman, J., Greer, I., May, A., Murphy, M., Ouwehand, W. and Watson, S. (2003) "BCSH Guidelines for the investi-gation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy", British Journal of Haematology 120, 574–596.
   PubMed Web of Science ®Google Scholar
• Frederiksen, H. and Schmidt, K. (1999) "The incidence of idiopathic thrombocytopenic purpura in adults increases with age", Blood 94, 909–913.
   PubMed Web of Science ®Google Scholar
• Ben-Yehuda, D., Gillis, S. and Eldor, A. (1994) "Clinical and therapeutic experience in 712 Israeli patients with idiopathic thrombocytopenic purpura. Israeli ITP Study Group", Acta Haematologica 91, 1–6.
   PubMed Web of Science ®Google Scholar
• Stasi, R., Stipa, E., Masi, M., Cecconi, M., Scimo, M.T., Oliva, F., Sciarra, A., Perrotti, A.P., Adomo, G., Amadori, S., et al. (1995) "Long-term observation of 208 adults with chronic idiopathic thrombocytopenic purpura", American Journal of Medicine 98, 436–442.
   PubMed Web of Science ®Google Scholar
• Mazzucconi, M.G., Francesconi, M., Fidani, P., Di Nucci, G., Gandolfo, G.M., Afeltra, A., Masala, C., Di Prima, M., Rocchi, G., Resta, S. and Mandelli, F. (1985) "Treatment of idiopathic thrombocytopenic purpura (ITP): results of a multicentric protocol", Haematologica 70, 329–336.
   PubMed Web of Science ®Google Scholar
• Blanchette, V, Freedman, J. and Garvey, B. (1998) "Manage-ment of chronic immune thrombocytopenic purpura in children and adults", Seminars in Hematology 35, 36–51.
   PubMed Web of Science ®Google Scholar
• Bellucci, S., Charpak, Y, Chastang, C. and Tobelem, G. (1988) "Low doses v conventional doses of corticoids in immune thrombocytopenic purpura (ITP): results of a randomized clinical trial in 160 children, 223 adults", Blood 71, 1165–1169.
   PubMed Web of Science ®Google Scholar
• Berchtold, P. and McMillan, R. (1989) "Therapy of chronic idiopathic thrombocytopenic purpura in adults", Blood 74, 2309–2317.
   PubMed Web of Science ®Google Scholar
• Manoharan, A. (1991) "Treatment of refractory idiopathic thrombocytopenic purpura in adults", British Journal of Haematology 79, 143–147.
   PubMed Web of Science ®Google Scholar
• Pizzuto, J. and Ambriz, R. (1984) "Therapeutic experience on 934 adults with idiopathic thrombocytopenic purpura: multicentric trial of the Cooperative Latin American group on Hemostasis and Thrombosis", Blood 64, 1179–1183.
   PubMed Web of Science ®Google Scholar
• Dwyer, J.M. (1992) "Manipulating the immune system with immune globulin", New England Journal of Medicine 326, 107–116.
   PubMed Web of Science ®Google Scholar
• Newland, A.C., Treleaven, J.G., Minchinton, R.M. and Waters, A.H. (1983) "High-dose intravenous IgG in adults with autoimmune thrombocytopenia", Lancet 1, 84–87.
   PubMed Web of Science ®Google Scholar
• Jacobs, P., Wood, L. and Novitzky, N. (1994) "Intravenous gammaglobulin has no advantages over oral corticosteroids as primary therapy for adults with immune thrombocyto-penia: a prospective randomized clinical trial", American Journal of Medicine 97, 55–59.
   PubMed Web of Science ®Google Scholar
• Godeau, B., Lesage, S., Divine, M., Wirquin, V, Farcet, J.P. and Bierling, P. (1993) "Treatment of adult chronic autoimmune thrombocytopenic purpura with repeated high-dose intravenous immunoglobulin", Blood 82, 1415–1421.
   PubMed Web of Science ®Google Scholar
• Chong, B.H. (1995) "Diagnosis, treatment and pathophysiol-ogy of autoimmune thrombocytopenias", Critical Reviews in Oncology/Hematology 20, 271–296.
   PubMed Web of Science ®Google Scholar
• Crow, A.R., Song, S., Semple, J.W., Freedman, J. and Lazarus, A.H. (2001) "IVIg inhibits reticuloendothelial system function and ameliorates murine passive-immune thrombo-cytopenia independent of anti-idiotype reactivity", British Journal of Haematology Dec; 115(3), 679–686.
   PubMed Web of Science ®Google Scholar
• Schiavotto, C., Ruggeri, M. and Rodeghiero, F. (1993) "Adverse reactions after high-dose intravenous immuno-globulin: incidence in 83 patients treated for idiopathic thrombocytopenic purpura (ITP) and review of the literature", Haematologica 78, 35–40.
   PubMedGoogle Scholar
• Cayco, A.V., Perazella, M.A. and Hayslett, J.P. (1997) "Renal insufficiency after intravenous immune globulin therapy: a report of two cases and an analysis of the literature", Journal of the American Society of Nephrology 8, 1788–1794.
   PubMed Web of Science ®Google Scholar
• Facon, T., Caulier, M.T., Fenaux, P., Plantier, I., Marchandise, X., Ribet, M., Jouet, J.P. and Bauters, F. (1992) "Accessory spleen in recurrent chronic immune thrombocytopenic purpura", American Journal of Hematology 41, 184–189.
   PubMed Web of Science ®Google Scholar
• Marcaccio, M.J. (2000) "Laparoscopic splenectomy in chronic idiopathic thrombocytopenic purpura", Seminars in Hematology 37, 267–274.
   PubMed Web of Science ®Google Scholar
• Najean, Y., Rain, J.-D. and Billotey, C. (1997) "The site of destruction of autologous 11n-labelled platelets and the efficiency of splenectomy in children and adults with idiopathic thrombocytopenic purpura: a study of 578 patients with 268 splenectomies", British Journal of Haemato-logy 97, 547–550.
   PubMed Web of Science ®Google Scholar
• Cavenagh, J.D., Macey, M.G., Newell, MS., Garvey, N. and Newland, A.C. (1999) "Predicting the outcome of splenec-tomy in ITP patients utilising 111 In-labelled platelet studies", British Journal of Haematology 105, 48.
   Web of Science ®Google Scholar
• Law, C., Marcaccio, M., Tam, P., Heddle, N. and Kelton, J.G. (1997) "High-dose intravenous immune globulin and the response to splenectomy in patients with idiopathic thrombocytopenic purpura", New England Journal of Medi-cine 336, 1494–1498.
   PubMed Web of Science ®Google Scholar
• Gillis, S. and Eldor, A. (1998) "Immune thrombocytopenic purpura: clinical aspects", Bailliere's Clinical Haematology 11, 361–372.
   PubMedGoogle Scholar
• Portielje, J.E., Westendorp, R.G., Kluin-Nelemans, H.C. and Brand, A. (2001) "Morbidity and mortality in adults with idiopathic thrombocytopenic purpura", Blood 97, 2549–2554.
   PubMed Web of Science ®Google Scholar
• Naouri, A., Feghali, B., Chabal, J., Boulez, J., Dechavanne, M., Viala, J.J. and Tissot, E. (1993) "Results of splenectomy for idiopathic thrombocytopenic purpura. Review of 72 cases", Acta Haematologica 89, 200–203.
   PubMed Web of Science ®Google Scholar
• Zarrabi, M.D. and Rosner, F. (1984) "Serious infections in adults following splenectomy", Archives of Internal Medicine 144, 1421–1424.
   PubMed Web of Science ®Google Scholar
• British Committee for Standards in Haematology Haemato-Oncology Task Force (2002) "Update of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen", Clinical Medicine 2, 440–443.
   PubMed Web of Science ®Google Scholar
• Andersen, J.C. (1994) "Response of resistant idiopathic thrombocytopenic purpura to pulsed high-dose dexametha-sone therapy", New England Journal of Medicine 330, 1560–1564.
   PubMed Web of Science ®Google Scholar
• Caulier, UT., Rose, C., Roussel, M.T., Huart, C., Bauters, F. and Fenaux, E (1995) "Pulsed high-dose dexamethasone in refractory chronic idiopathic thrombocytopenic purpura: a report on 10 cases", British Journal of Haematology 91, 477–479.
   PubMed Web of Science ®Google Scholar
• Arruda, V.R. and Annichino-Bizzacchi, J.M. (1996) "High-dose dexamethasone therapy in chronic idiopathic thrombo-cytopenic purpura", Annals of Hematology 73, 175–177.
   PubMed Web of Science ®Google Scholar
• Akoglu, T., Paydas, S., Bayik, M., Lawrence, R. and Firatli, T. (1991) "Megadose methylprednisolone pulse therapy in adult idiopathic thrombocytopenic purpura", Lancet 337, 56.
   PubMed Web of Science ®Google Scholar
• von dem Borne, A.E., Vos, J.J., Pegels, J.G., Thomas, L.L. and van der, L. (1988) "High dose intravenous methylpredniso-lone or high dose intravenous gammaglobulin for auto-immune thrombocytopenia", British Medical Journal (Clinical Research Edition) 296, 249–250.
   PubMed Web of Science ®Google Scholar
• Blanchette, VS., Luke, B., Andrew, M., Sommerville-Nielsen, S., Barnard, D., de Veber, B. and Gent, M. (1993) "A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura", Journal of Pediatrics 123, 989–995.
   PubMed Web of Science ®Google Scholar
• Scaradavou, A., Woo, B., Wolosld, B.M., Cunningham-Rundles, S., Ettinger, L.J., Aledort, L.M. and Bussel, J.B. (1997) "Intravenous anti-D treatment of immune thrombocytopenic purpura: experience in 272 patients", Blood 89, 2689–2700.
   PubMed Web of Science ®Google Scholar
• Cooper, N., Woloski, B.M., Fodero, E.M., Novoa, M., Leber, M., Beer, J.H. and Bussel, J.B. (2002) "Does treatment with intermittent infusions of intravenous anti-D allow a proportion of adults with recently diagnosed immune thrombocytopenic purpura to avoid splenectomy?", Blood 99, 1922–1927.
   PubMed Web of Science ®Google Scholar
• Ahn, Y.S., Rocha, R., Mylvaganam, R., Garcia, R., Duncan, R. and Harrington, W.J. (1989) "Long-term danazol therapy in autoimmune thrombocytopenia: unmaintained remission and age dependent response in women", Annals of Internal Medicine 111, 723–729.
   PubMed Web of Science ®Google Scholar
• Schneider, P, Wehmeier, A. and Schneider, W. (1997) "High-dose intravenous immune globulin and the response to splenectomy in patients with idiopathic thrombocytopenic purpura", New England Journal of Medicine 337, 1087–1088.
   PubMed Web of Science ®Google Scholar
• Quiquandon, I., Fenaux, P., Caulier, M.T., Pagniez, D., Huart, J.J. and Bauters, E (1990) "Re-evaluation of the role of azathioprine in the treatment of adult chronic idiopathic thrombocytopenic purpura: a report on 53 cases", British Journal of Haematology 74, 223–228.
   PubMed Web of Science ®Google Scholar
• Kappers-Klunne, M.C. and van't Veer, M.B. (2001) "Cyclo-sporin A for the treatment of patients with chronic idiopathic thrombocytopenic purpura refractory to cortico-steroids or splenectomy", British Journal of Haematology 114, 121–125.
   PubMed Web of Science ®Google Scholar
• Emilia, G., Morselli, M., Luppi, M., Longo, G., Marasca, R., Gandini, G., Ferrara, L., D'Apollo, N., Potenza, L., Bertesi, M. and Torelli, G. (2002) "Long-term salvage therapy with cyclosporin A in refractory idiopathic thrombocytopenic purpura", Blood 99, 1482–1485.
   PubMed Web of Science ®Google Scholar
• Godeau, B., Durand, J.M., Roudot-Thoraval, E, Tenneze, A., Oksenhendler, E., Kaplanski, G., Schaeffer, A. and Bierling, P. (1997) "Dapsone for chronic autoimmune thrombocytopenic purpura: a report of 66 cases", British Journal of Haematology 97, 336–339.
   PubMed Web of Science ®Google Scholar
• Radaelli, E, Calori, R., Goldaniga, M., Guggiari, E. and Luciano, A. (1999) "Adult refractory chronic idiopathic thrombocytopenic purpura: can dapsone be proposed as second-line therapy?", British journal of Haematology 104, 641–642.
   PubMed Web of Science ®Google Scholar
• Hernandez, F., Linares, M., Colomina, P., Pastor, E., Cervero, A., Perez, A. and Perella, M. (1995) "Dapsone for refractory chronic idiopathic thrombocytopenic purpura", British Journal of Haematology 90, 473–475.
   PubMed Web of Science ®Google Scholar
• George, J.N., el-Harake, M.A. and Raskob, G.E. (1994) "Chronic idiopathic thrombocytopenic purpura", New England Journal of Medicine 331, 1207–1211.
   PubMed Web of Science ®Google Scholar
• Kuwana, M., Kawakami, Y. and Ikeda, Y. (2003) "Suppres-sion of autoreactive T-cell response to glycoprotein /Ma by blockade of CD40 /CD154 interaction: implications for treatment of immune thrombocytopenic purpura", Blood 101, 621–623.
   PubMed Web of Science ®Google Scholar
• Howard, J., Hoffbrand, A.V., Prentice, H.G. and Mehta, A. (2002) "Mycophenolate mofetil for the treatment of refractory auto-immune haemolytic anaemia and auto-immune thrombocytopenia purpura", British Journal of Haematology 117, 712–715.
   PubMed Web of Science ®Google Scholar
• Snyder, Jr., H.W., Cochran, S.K., Balint, Jr., J.P., Bertram, J.H., Mittelman, A., Guthrie, Jr., T.H. and Jones, ER. (1992) "Experience with protein A-immunoadsorption in treat-ment-resistant adult immune thrombocytopenic purpura", Blood 79, 2237–2245.
   PubMed Web of Science ®Google Scholar
• Cahill, M.R., Macey, M.G., Cavenagh, J.D. and Newland, A.C. (1998) "Protein A immunoadsorption in chronic refractory ITP reverses increased platelet activation but fails to achieve sustained clinical benefit", British Journal of Haematology 100, 358–364.
   PubMed Web of Science ®Google Scholar
• Karpatkin, S. (1997) "Autoimmune (idiopathic) thrombocyto-penic purpura", Lancet 349, 1531–1536.
   PubMed Web of Science ®Google Scholar
• Hegde, UP., Wilson, W.H., White, T. and Cheson, B.D. (2002) "Rituximab treatment of refractory fludarabine-associated immune thrombocytopenia in chronic lymphocytic leuke-mia", Blood 100, 2260–2262.
   PubMed Web of Science ®Google Scholar
• Hale, G. (1995) "Synthetic peptide mimotope of the CAMPATH-1 (CD52) antigen, a small glycosylphosphati-dylinositol-anchored glycoprotein", Immunotechnology 1, 175–187.
   PubMedGoogle Scholar
• Willis, E, Marsh, J.C., Bevan, D.H., Killick, S.B., Lucas, G., Griffiths, R., Ouwehand, W., Hale, G., Waldmann, H. and Gordon-Smith, E.C (2001) "The effect of treatment with Campath-1H in patients with autoimmune cytopenias", British Journal of Haematology 114, 891–898.
   PubMed Web of Science ®Google Scholar
• Lim, S.H., Hale, G., Marcus, R.E., Waldmann, H. and Baglin, T.P. (1993) "CAMPATH-1 monoclonal antibody therapy in severe refractory autoimmune thrombocytopenic purpura", British Journal of Haematology 84, 542–544.
   PubMed Web of Science ®Google Scholar
• Gasbarrini, A., Franceschi, F., Tartaglione, R., Landolfi, R., Pola, P. and Gasbarrini, G. (1998) "Regression of auto-immune thrombocytopenia after eradication of Helicobacter pylori", Lancet 352, 878.
   PubMed Web of Science ®Google Scholar
• Proctor, S.J., Jackson, G., Carey, P., Stark, A., Finney, R., Saunders, P., Summerfield, G., Maharaj, D. and Youart, A. (1989) "Improvement of platelet counts in steroid-unrespon-sive idiopathic immune thrombocytopenic purpura after short-course therapy with recombinant alpha 2b interferon", Blood 74, 1894-1897, 175–179.
   Google Scholar
• Matthey, E, Ardeman, S., Jones, L. and Newland, A.C. (1990) "Bleeding in immune thrombocytopenic purpura after alphainterferon", Lancet 335, 471–472.
   PubMed Web of Science ®Google Scholar
• Vianelli, N., Tazzari, Baravelli, S., Ricci, F., Valdre, L.and Tura, S. (1998) "Interferon-alpha 2b is not effective in the treatment of refractory immune thrombocytopenic pur-pura", Haematologica 83, 761–763.
   PubMed Web of Science ®Google Scholar
• Figueroa, M., Gehlsen, J., Hammond, D., Ondreyco, S., Piro, L., Pomeroy, T., Williams, E and McMillan, R. (1993) "Combination chemotherapy in refractory immune thrombocytopenic purpura", New England Journal of Medi-cine 328, 1226–1229.
   PubMed Web of Science ®Google Scholar
• Passweg, J.R., Rabusin, M., Musso, M., Beguin, Y., Ehninger, G., Juergens, H., Koza, V, Lisukov, I., Marmont, M., Philippe, P., Quartier, P., Vavrinec, J., Tyndall, A. and Gratwohl, A. (2001) "Autologous stem cell transplantation for refractory autoimmune thrombocytopenias", Blood 98, 2874.
   Google Scholar
• Huhn, R.D., Fogarty, P.F., Nakamura, R., Read, E.J., Leitman, S.F., Rick, M.E., Kimball, J., Greene, A., Hansmarm, K., Gratwohl, A., Young, N., Barrett, A.J. and Dunbar, C.E. (2003) "High-dose cyclophosphamide with autologous lymphocyte-depleted peripheral blood stem cell (PBSC) support for treatment of refractory chronic autoimmune thrombocytopenia", Blood 101, 71–77.
   PubMed Web of Science ®Google Scholar
• Rice, L., Nichol, J.L., McMillan, R., Roskos, L.K. and Bacile, M. (2001) "Cyclic immune thrombocytopenia responsive to thrombopoietic growth factor therapy", American Journal of Hematology 68, 210–214.
   PubMed Web of Science ®Google Scholar
• Vidarsson, B. and Onundarson, P.T. (2000) "Recombinant factor Villa for bleeding in refractory thrombocytopenia", Thrombosis and Haemostasis 83, 634–635.
   PubMed Web of Science ®Google Scholar
• Carr, J.M., Kruskall, M.S., Kaye, J.A. and Robinson, S.H. (1986) "Efficacy of platelet transfusions in immune thrombocytopenia", American Journal of Medicine 80, 1051–1054.
   PubMed Web of Science ®Google Scholar
• Cohen, Y.C., Djulbegovic, B., Shamai-Lubovitz, O. and Mozes, B. (2000) "The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts", Archives of Internal Medicine 160, 1630–1638.
   PubMed Web of Science ®Google Scholar
• Collins, P.W. and Newland, A.C. (1992) "Treatment modalities of autoimmune blood disorders", Seminars in Hematology 29, 64–74.
   PubMed Web of Science ®Google Scholar